MRI scan study to characterize lower-grade brain tumors
Treatments studied
Part of Cancer clinical trials.
This Phase 1 study uses special MRI scans (including a form of MR spectroscopy) to better understand lower-grade gliomas. It is designed to test how well the imaging can “characterize” the tumor and to improve understanding for treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed lower-grade glioma, or a confirmed glioma that may have come back or not fully been removed
- Your doctor expects you can live at least 12 weeks
- Your daily function level (Karnofsky score) is 60 or higher
- You can have a kidney blood test showing good kidney function (creatinine under 1.5) within 60 days of the special scan
- You do not have serious heart problems that are hard to control, including certain congestive heart failure or recent heart attack/unstable chest pain
- You can follow study visits and sign consent to have your health information shared
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.
This study tests a new MRI scanning method to see if it can better monitor glioblastoma after standard treatment. It may help doctors detect tumor changes earlier and guide future care.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
Hear when a new WHO Grade II Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.